Atossa Therapeutics, Inc(NASDAQ:ATOS) 
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cance...
Website: http://www.atossagenetics.com
Founded: 2008
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.64
H 0.64
L 0.60
C 0.60
V 1,504,953
10EMA 0.60
20EMA 0.60
60EMA 0.60
120EMA 0.60
250EMA 0.60